| Loren D Cooper, MD | |
|
1800 Cooks Hill Rd, Suite B, Centralia, WA 98531-9072 | |
| (360) 330-8591 | |
| Not Available |
| Full Name | Loren D Cooper |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1800 Cooks Hill Rd, Centralia, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649267196 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD00015204 (Washington) | Primary |
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376624981 PECOS PAC ID: 9234048323 Enrollment ID: O20040227000254 |
News Archive
Tumor cells are able to avoid the attack of the immune system through several mechanisms. For instance, these can secrete factors that turn macrophages -cells in the immune system- into dual action agents that contribute to the tumor progress and will protect it from immune body defenses: these become, thus, the tumor-associated macrophages (TAMs).
Part of the reason for the decision may have been the result of political and public pressure, but an unexpected development may have made the retreat easier for the company to accept — it's paying out less than expected for claims.
Researchers at Harvard Medical School and Columbia University in the United States have developed a way to study the functions of hard-to-grow bacteria that contribute to the composition of the gut microbiome. The new method is published in the journal Molecular Systems Biology.
While Parkinson's disease typically brings to mind symptoms such as tremors and slow movement, researchers have found that nearly half of all Parkinson's patients also suffer from depression. While it might seem natural that someone who has a disease such as Parkinson's might become depressed, it's not so simple, says neurologist Irene Richard, M.D., who leads the study.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that Bayer HealthCare Pharmaceuticals' submission of an Investigational New Drug (IND) application for the TAP compound, BAY 94-9343, triggers a $2 million milestone payment to ImmunoGen.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Loren D Cooper, MD 1800 Cooks Hill Rd, Suite B, Centralia, WA 98531-9072 Ph: (360) 330-8591 | Loren D Cooper, MD 1800 Cooks Hill Rd, Suite B, Centralia, WA 98531-9072 Ph: (360) 330-8591 |
News Archive
Tumor cells are able to avoid the attack of the immune system through several mechanisms. For instance, these can secrete factors that turn macrophages -cells in the immune system- into dual action agents that contribute to the tumor progress and will protect it from immune body defenses: these become, thus, the tumor-associated macrophages (TAMs).
Part of the reason for the decision may have been the result of political and public pressure, but an unexpected development may have made the retreat easier for the company to accept — it's paying out less than expected for claims.
Researchers at Harvard Medical School and Columbia University in the United States have developed a way to study the functions of hard-to-grow bacteria that contribute to the composition of the gut microbiome. The new method is published in the journal Molecular Systems Biology.
While Parkinson's disease typically brings to mind symptoms such as tremors and slow movement, researchers have found that nearly half of all Parkinson's patients also suffer from depression. While it might seem natural that someone who has a disease such as Parkinson's might become depressed, it's not so simple, says neurologist Irene Richard, M.D., who leads the study.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that Bayer HealthCare Pharmaceuticals' submission of an Investigational New Drug (IND) application for the TAP compound, BAY 94-9343, triggers a $2 million milestone payment to ImmunoGen.
› Verified 3 days ago
Dr. Richard Scott Elloway, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 S. Scheuber Road, Suite G, Centralia, WA 98531 Phone: 360-330-8808 Fax: 360-330-8816 | |
David Fick, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 914 S Scheuber Rd, Centralia, WA 98531 Phone: 360-736-2803 | |
Eric S Swanson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 914 S Scheuber Rd, Centralia, WA 98531 Phone: 360-827-8811 | |
Dr. Jong-wook Ban, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 S Scheuber Rd Ste 3&4, Centralia, WA 98531 Phone: 360-827-7966 Fax: 360-827-7977 | |
Dr. Romil Wadhawan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 S Scheuber Rd, Suite 3&4, Centralia, WA 98531 Phone: 360-807-7966 Fax: 360-807-7977 | |
Dr. Floyd D Smith, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1611 Kresky Ave, Suite 112, Centralia, WA 98531 Phone: 360-330-2023 Fax: 360-623-1585 | |
Katie Elizabeth Kunnen, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 914 S Scheuber Rd, Centralia, WA 98531 Phone: 360-827-8811 Fax: 360-330-8969 |